Jordan Winter, MD
-
Specialty: Surgical Oncology, General Surgery
View Expertise -
Primary Location: 3800 Embassy Pkwy (25 mi.)
Other Locations - Languages Spoken: English
Office Locations
UH Fairlawn Health Center (25 mi.)
3800 Embassy Pkwy
Ste 250
Akron, OH 44333
330-664-8160
DO Bolwell 2100 (0 mi.)
11100 Euclid Ave
Bolwell Ste 2100
Cleveland, OH 44106
216-844-7874
UH Minoff Health Center at Chagrin Highlands (7 mi.)
3909 Orange Pl
Ste 4600
Beachwood, OH 44122
216-896-1750
UH Seidman Cancer Center (22 mi.)
2075 Healthway Dr
2nd Floor
Avon, OH 44011
440-517-9000
Biography: Jordan Winter, MD
Expertise
Titles
- Director, Surgical Services, UH Seidman Cancer Center
- Division Chief, Surgical Oncology, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Certifications & Memberships
- Surgery - American Board of Surgery
Education
Fellowship | Surgical Oncology
Surgical Oncology - Memorial Sloan-Kettering Cancer Center (2009 - 2011)
Residency | General Surgery
General Surgery - Johns Hopkins Hospital (2007 - 2009)
Research Fellowship | Surgical Oncology
Surgical Oncology - Johns Hopkins Hospital (2004 - 2007)
Residency | General Surgery
General Surgery - Johns Hopkins Hospital (2001 - 2004)
Medical Education
Weill Cornell Medical College (2001)
Undergraduate
Princeton University (1997)
About
Member, GI Cancer Genetics Program, Case Comprehensive Cancer Center
Jordan M. Winter, MD is a nationally recognized, board-certified surgeon with a special interest in the medical and surgical management of pancreatic and related cancers, pancreatic cysts, chronic pancreatitis, bile duct strictures, biliary, gastric and liver cancers and abdominal tumors.
In addition to being a highly skilled clinician, Dr. Winter is a leader in translational and basic research. As director of the Winter Lab, which is funded by the American Cancer Society and the NIH, he is at the forefront of investigational efforts to find alternative treatments for pancreatic cancer. The lab seeks to understand how pancreatic cancer cells survive in their microenvironment and identify their metabolic weaknesses to ultimately discover new and effective therapies. A clinical study will soon be underway to study the use of a novel metabolic inhibitor.
With 18 years of experience, Dr. Winter has made significant contributions to his field of study and has authored more than 100 peer-reviewed articles and a dozen book chapters, many of which focus on pancreatic cancer. He excels in his role as educator and is committed to helping his colleagues reach their professional goals.
Dr. Winter uses a unique blend of science and compassion in his approach to health care and has dedicated his career to helping patients who face the most challenging cancers. With two office locations in Cleveland and Beachwood, patients across the region have convenient access to his expertise. He also consults with people across the country through UH’s unique Telehealth program.
Dr. Winter has an impressive educational background. He received his undergraduate degree from Princeton University in 1997 and his medical degree from Weill Cornell Medical College in New York, graduating in 2001. After completing a general surgery residency at Johns Hopkins Hospital in Baltimore, Dr. Winter further honed his expertise at Memorial Sloan-Kettering Cancer Center in New York, where he completed a two-year fellowship in surgical oncology.
Featured Videos
Watch to find out more about this University Hospitals physician.
Related Blog Articles
Research: High Blood Sugar Makes Chemotherapy More Effective
The findings reveal a new way to treat cancer that would be low cost and could be easily tested in other patients with cancer.
Catching Pancreatic Cancer Early to Rewrite Her Story
Beverly Leighton had a strong family history of pancreatic cancer. Her decision to be proactive and begin yearly screenings at University Hospitals likely saved her life.
Clinical Trials Key to Survival for Pancreatic Cancer Patients
When 63-year-old George Miller experienced a 30-pound weight loss over a short period of time along with other severe symptoms, he knew something was wrong. Tests confirmed pancreatic cancer and George turned to University Hospitals for help.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Jordan Winter did not disclose any Outside Relationships with Industry.